<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02198612</url>
  </required_header>
  <id_info>
    <org_study_id>RC14_0226</org_study_id>
    <nct_id>NCT02198612</nct_id>
  </id_info>
  <brief_title>FREEDOM: &quot;Pilot Study of the Feasibility and Safety of Resuming Early Walking After Manual Compression in Patients Treated for Peripheral Artery Disease by Endovascular Technique Involving Retrograde Femoral Puncture&quot;</brief_title>
  <acronym>FREEDOM</acronym>
  <official_title>FREEDOM: &quot;Pilot Study of the Feasibility and Safety of Resuming Early Walking After Manual Compression in Patients Treated for Peripheral Artery Disease by Endovascular Technique Involving Retrograde Femoral Puncture&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Over the past years, arterial closure systems have tended to replace manual compression to&#xD;
      ensure hemostasis at femoral artery puncture points. Arterial closure systems reduce&#xD;
      hemostasis and patient immobilization times, thus enabling early resumption of walking. These&#xD;
      devices have contributed extensively to the development of outpatient stays for cardiology,&#xD;
      vascular and neuro-radiology procedures.&#xD;
&#xD;
      According to certain studies however, it would appear that arterial closure devices do not&#xD;
      present any greater benefits than manual compression in terms of hemostasis and&#xD;
      complications. Moreover, the use of increasingly small diameter instruments would tend to&#xD;
      render manual compression sufficient. Finally, the use of these devices generates additional&#xD;
      costs.&#xD;
&#xD;
      The purpose of our study is to evaluate the feasibility and safety of manual compression&#xD;
      before early resumption of walking in patients managed by conventional hospitalization for a&#xD;
      diagnostic or therapeutic endovascular procedures by retrograde femoral puncture with 5F&#xD;
      guide catheter.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Resumption of walking at H5 will be evaluated by a walking test</measure>
    <time_frame>Hour 5</time_frame>
    <description>To demonstrate the feasibility of early resumption of walking after manual puncture point compression following a diagnostic or therapeutic procedure by endovascular technique involving retrograde femoral puncture point with 5F guide catheter.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurrence of major punctured femoral triangle events during the perioperative period, requiring prolongation of hospitalization, repeat hospitalization or repeat surgery (hematoma, hemorrhage or false aneurysm)</measure>
    <time_frame>Hour 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of minor punctured femoral triangle events during the perioperative period, not requiring prolongation of hospitalization, repeat hospitalization or repeat surgery</measure>
    <time_frame>Hour 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to onset of complications</measure>
    <time_frame>Hour 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Puncture point pain (visual analog scale of pain)</measure>
    <time_frame>Hour 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life evaluation (EQ5D questionnaire)</measure>
    <time_frame>Month 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compression time</measure>
    <time_frame>Hour 5</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <arm_group>
    <arm_group_label>Manual puncture point compression</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Manual puncture point compression following a diagnostic or therapeutic procedure by endovascular technique involving retrograde femoral puncture point with 5F guide catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Manual puncture point compression</intervention_name>
    <description>Manual puncture point compression following a diagnostic or therapeutic procedure by endovascular technique involving retrograde femoral puncture point with 5F guide catheter</description>
    <arm_group_label>Manual puncture point compression</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 years,&#xD;
&#xD;
          -  Endovascular examination or treatment compatible with a 5F guide catheter&#xD;
&#xD;
          -  Walking ability&#xD;
&#xD;
          -  Patient affiliated with a social security scheme&#xD;
&#xD;
          -  Patient's signed informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Underage patient&#xD;
&#xD;
          -  Patient of age, but under legal guardianship or care&#xD;
&#xD;
          -  Contraindication to endovascular treatment&#xD;
&#xD;
          -  Use of a 6F or greater guide catheter&#xD;
&#xD;
          -  Morbidity contraindicating same-day walking&#xD;
&#xD;
          -  History of punctured open femoral triangle surgery&#xD;
&#xD;
          -  Radial or humeral puncture&#xD;
&#xD;
          -  Bilateral femoral puncture&#xD;
&#xD;
          -  Anterograde femoral puncture&#xD;
&#xD;
          -  Acute ischemia&#xD;
&#xD;
          -  Anticoagulant treatment&#xD;
&#xD;
          -  Allergy to ElastoplastÂ® type adhesive strips&#xD;
&#xD;
          -  Life expectancy of less than one month&#xD;
&#xD;
          -  Patient refusal to take part in the study&#xD;
&#xD;
          -  Participation in another therapeutic trial&#xD;
&#xD;
          -  Pregnant woman&#xD;
&#xD;
          -  Patients who do not speak French, refusing or incapable of the follow-up proposed by&#xD;
             the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yann GOUEFFIC, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Nantes University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <study_first_submitted>July 15, 2014</study_first_submitted>
  <study_first_submitted_qc>July 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2014</study_first_posted>
  <last_update_submitted>December 22, 2015</last_update_submitted>
  <last_update_submitted_qc>December 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

